Proton Therapy Academy: Advancing Education, Collaboration, and Innovation in Proton Therapy
As proton therapy continues to grow globally, the demand for accessible, high-quality education and cross-institutional collaboration has never been greater, particularly in centers staffed by teams of varying experience and training. Proton Therapy Academy (PTA) is a global hub, endorsed by PTCOG, dedicated to closing the proton therapy staff-readiness gap. By connecting comprehensive online learning with hands-on clinical internships, PTA helps teams move from knowledge to treatment, faster and more safely.
At the heart of PTA is the Proton Therapy Academy Network, which brings together leading centers worldwide to codevelop peer-reviewed, role-based learning pathways. Radiation oncologists, medical physicists, dosimetrists, radiation therapy technologists, and nurses each progress through tailored curricula that blend flexible online modules, completed at the professional’s own pace, with immersive onsite practice in partner centers. Courses, educational events, and equipment training are curated in one place, designed expressly for the proton therapy community and equally relevant to both emerging and established centers.
Over the past year, PTA has continued to expand both its reach and impact. A key initiative is the Proton Therapy Optimization webinar series, which features practical, implementable techniques and real-world insights from Network experts. These sessions are designed to help centers improve workflows, clinical practices, operational efficiency, and patient care through peer-to-peer knowledge exchange and have attracted a growing international audience. To stay up to date on upcoming webinars and educational initiatives, follow Proton Therapy Academy on LinkedIn.
Learn more about Proton Therapy Academy at ProtonTherapy-Academy.com. As proton therapy continues to advance worldwide, PTA remains committed to supporting the global community through high-quality, evidence-based education, practical training, and collaborative initiatives that drive innovation and help ensure broader, safer access to advanced cancer care for patients everywhere.
